GENEVA, July 2 -- ETH ZÜRICH filed a patent application (EP2025/088364) for “4-OXORETINOATE FOR USE IN POST-MYOCARDIAL INFARCTION THERAPY”. With publication no. WO/2026/132425, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/203
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....